Percutaneous Coronary Intervention Clinical Trials

43 recruiting

Percutaneous Coronary Intervention Trials at a Glance

60 actively recruiting trials for percutaneous coronary intervention are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Beijing, Seoul, and Amsterdam. Lead sponsors running percutaneous coronary intervention studies include Xijing Hospital, Genoss Co., Ltd., and China National Center for Cardiovascular Diseases.

Browse percutaneous coronary intervention trials by phase

Treatments under study

About Percutaneous Coronary Intervention Clinical Trials

Looking for clinical trials for Percutaneous Coronary Intervention? There are currently 43 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Percutaneous Coronary Intervention trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Percutaneous Coronary Intervention clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 60 trials

Recruiting
Not Applicable

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Diffuse Coronary Artery Disease
University Hospital, Geneva150 enrolled1 locationNCT06710210
Recruiting
Not Applicable

Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).

Chronic Coronary SyndromeCoronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)+6 more
Spanish Society of Cardiology50 enrolled6 locationsNCT06736665
Recruiting
Not Applicable

ELEVATE High-Risk PCI Pivotal Study

High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Magenta Medical Ltd.290 enrolled29 locationsNCT07001332
Recruiting

Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction

Coronary Arterial Disease (CAD)Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Azienda Ospedaliera di Bolzano1,500 enrolled1 locationNCT06910436
Recruiting
Phase 4

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University6,000 enrolled78 locationsNCT06909565
Recruiting
Not Applicable

Video-based Intervention to Reduce Anxiety in Patients Undergoing Elective PCI

Coronary Artery DiseaseProcedural AnxietyPercutaneous Coronary Intervention Patients
Tan Tock Seng Hospital144 enrolled1 locationNCT07485088
Recruiting

Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients

Coronary Artery DiseasePercutaneous Coronary InterventionTranscatheter Aortic Valve Implantation (TAVI)+2 more
National Taiwan University Hospital157 enrolled1 locationNCT07469397
Recruiting
Phase 4

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
J.P.S Henriques300 enrolled1 locationNCT06916520
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Acute Myocardial InfarctionPercutaneous Coronary Intervention (PCI)
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting
Not Applicable

IVUS-FFR Accuracy for Coronary Stenosis

Percutaneous Coronary InterventionIntravenous UltrasoundCoronary Physiology
China National Center for Cardiovascular Diseases292 enrolled1 locationNCT07446023
Recruiting

Study on the Preferences for PCI Implantation Devices Among Doctors and Patients

Coronary Artery DiseasePercutaneous Coronary Intervention
Xijing Hospital600 enrolled1 locationNCT07378163
Recruiting

Comparing the Components of Composite Endpoints for Healthcare Providers and Patients

Coronary Artery DiseasePercutaneous Coronary Intervention
Xijing Hospital600 enrolled1 locationNCT07378137
Recruiting

The 3D Stent Study

Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)
CoreAalst BV200 enrolled4 locationsNCT06898021
Recruiting

Cardio-Renal Registry

Myocardial InfarctionEnd Stage Renal DiseaseCerebrovascular Accident+3 more
Queen Mary University of London60,000 enrolled1 locationNCT06521801
Recruiting

Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions

Percutaneous Coronary InterventionCoronary Occlusion
National Institute of Cardiology, Warsaw, Poland1,000 enrolled21 locationsNCT07330622
Recruiting
Not Applicable

Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

Coronary Artery DiseasePercutaneous Coronary InterventionCoronary Occlusion
National Institute of Cardiology, Warsaw, Poland74 enrolled3 locationsNCT06878729
Recruiting
Phase 4

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Duk-Woo Park, MD3,320 enrolled43 locationsNCT04416581
Recruiting
Phase 2Phase 3

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Heart FailureAcute Kidney InjuryPercutaneous Coronary Intervention+2 more
VA Office of Research and Development240 enrolled3 locationsNCT04982419
Recruiting
Not Applicable

SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective

Coronary Artery DiseasePercutaneous Coronary InterventionStenosis Coronary+1 more
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS140 enrolled10 locationsNCT06373601
Recruiting
Phase 4

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention

Coronary Artery DiseasePercutaneous Coronary Intervention
Peking Union Medical College Hospital64 enrolled1 locationNCT03378934